Advertisement

Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: A replication

      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        3rd ed rev. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington, DC1987
        • Andreasen N.C.
        Scale for the Assessment of Negative Symptoms (SANS).
        University of Iowa, Iowa City1983
        • Andreasen N.C.
        • Olsen S.A.
        • Dennert J.W.
        • Smith M.R.
        Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms.
        Am J Psychiatry. 1982; 139: 297-302
        • Breier A.
        • Wolkowitz O.M.
        • Doran A.R.
        • Roy A.
        • Boronow J.
        • Hommer D.W.
        • Pickar D.
        Neuroleptic responsivity of positive and negative symptoms in schizophrenia.
        Am J Psychiatry. 1987; 144: 1549-1555
        • Carpenter W.T.
        • Heinrichs D.W.
        • Alphs L.D.
        Treatment of negative symptoms.
        Schizophrenia Bulletin. 1985; 11: 440-452
        • Crow T.J.
        Molecular pathology of schizophrenia: More than one disease process.
        Br Med J. 1980; 280: 1-9
        • Endicott J.
        • Spitzer R.L.
        A diagnostic interview: The schedule for affective disorders and schizophrenia.
        Arch Gen Psychiatry. 1978; 35: 837-844
        • Kay S.R.
        • Singh M.M.
        The positive-negative distinction in drug-free schizophrenic patients.
        Arch Gen Psychiatry. 1989; 46: 711-718
        • Meltzer H.Y.
        Pharmacological treatment of negative symptoms.
        in: Greden J.F. Tandon R. Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications. American Psychiatric Press, Washington DC1990: 217-231
        • Overall J.E.
        • Gorham D.R.
        Brief Psychiatric Rating Scale (BPRS).
        Psychol Rep. 1962; 10: 799-812
        • Serban G.
        • Siegel S.
        • Gaffney M.
        Response of negative symptoms of schizophrenia to neuroleptic treatment.
        J Clin Psychiatry. 1992; 53: 229-234
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research Diagnostic Criteria: Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Tandon R.
        • Greden J.F.
        Cholinergic hyperactivity and negative schizophrenic symptoms.
        Arch Gen Psychiatry. 1989; 46: 745-753
        • Tandon R.
        • Goldman R.S.
        • Goodson J.
        • Greden J.F.
        Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia.
        Biol Psychiatry. 1990; 27: 1323-1326
        • vanKammen D.P.
        • Hommer D.W.
        • Malas K.L.
        Effect of pimozide on positive and negative symptoms in schizophrenic patients: Are negative symptoms state dependent?.
        Neuropsychobiology. 1987; 18: 113-117